Report Finder

All Sentinel reports, surveillance tools, FDA assessments, and communication materials may be searched using the options below. Search results can be further sorted by title, project status, and date posted by clicking on the relevant column header. If you wish to search for FDA Center assessments more specifically by medical product and health outcome, please go to the CDER Assessments and CBER Assessments pages.

E.g., 1/25/2020
E.g., 1/25/2020
Title Status FDA Centersort ascending Date Posted
Use of Dabigatran and Intracranial Hemorrhage, Gastrointestinal Hemorrhage, Ischemic Stroke, and Acute Myocardial Infarction Complete CDER 08/17/2018
Boceprevir, Ledipasivir/Sofosbuvir, Simeprevir Sodium, Sofosbuvir, and Telaprevir Use In progress CDER 02/05/2018
Mycophenolate Dispensings and Procedures In progress CDER 12/01/2017
Duloxetine, Pregabalin, and Milnacipran Use 1 Complete CDER 01/09/2013
Indications of Intravenous Immunoglobulin Use Complete CDER 05/20/2016
Utilization Patterns of Qsymia (Phentermine/Topiramate) Complete CDER 08/07/2019
Lindane Use Summary Table Complete CDER 06/22/2012
New Pediatric Users of Leuprolide Acetate Depot Complete CDER 08/17/2018
Seizure following Ranolazine Use Complete CDER 01/03/2019
Oral Antifungal Use Complete CDER 11/20/2013
Mycophenolate Dispensings and Procedures (by Quarter) Complete CDER 12/01/2017
Duloxetine, Pregabalin, and Milnacipran Use 2 Complete CDER 01/09/2013
Omalizumab or Montelukast Use Among Individuals with Asthma and Acute Myocardial Infarction, Stroke, Intracranial Hemorrhage, or Pulmonary Embolism Complete CDER 06/21/2016
Neuropsychiatric Events following Montelukast Use: A Propensity Score Matched Analysis Complete CDER 09/27/2019
Regional Enteritis and Ulcerative Enterocolitis Diagnoses Complete CDER 06/22/2012
Algorithms Evaluating Dabigatran Use and Acute Myocardial Infarction Compared with Warfarin Complete CDER 08/23/2018
Diabetes Diagnoses and Occurrence of Laboratory Results Complete CDER 06/12/2014
Prevalent and Incident Dispensings of Ranolazine In progress CDER 02/26/2018
Occurrence of Selected Generic Drugs 10 Complete CDER 11/20/2013
Genetic Testing Procedures Complete CDER 12/05/2017
Selgiline Use Complete CDER 01/10/2013
Epidural Steroid Use Complete CDER 06/30/2016
Use of Angiotensin-Converting Enzyme (ACE) Inhibitors and Angiotensin Receptor Blockers (ARB) in a Pediatric Population Complete CDER 08/22/2019
Arthritis Diagnoses Complete CDER 06/22/2012
Select Bisphosphonates and Select Outcomes of Interest Complete CDER 03/14/2015
Sofosbuvir and Amiodarone Use and Bradycardia or Pacemaker Insertion Complete CDER 08/29/2018
Analgesic Use 3 In progress CDER 08/12/2014
Sinus Stents with Mometasone and Diminished Visual Acuity Complete CDER 09/12/2019
Antiepileptic Drug Use Complete CDER 11/20/2013
Antipsychotic Use and Dementia Diagnoses In progress CDER 12/07/2017
Clopidogrel and Prasugrel Use Complete CDER 01/09/2013
Dronedarone and Electrocardiograms Complete CDER 08/16/2016
Non-Melanoma Skin Cancer following Hydrochlorothiazide Use Complete CDER 09/12/2019
Quantifying Prevalence and Mortality Associated with Neonatal Enteroviral Sepsis (NES) Using Inpatient Data in FDA’s Sentinel System Complete CDER 11/27/2018
Anti-Infective Agents Use 2 In progress CDER 09/23/2014
Use of Tyrosine Kinase Inhibitors (TKIs) Complete CDER 02/28/2018
A Protocol for Assessment of Dabigatran and Selected Safety Outcomes Complete CDER 01/26/2018
Incident and Prevalent Use of Generic Drugs for Overactive Bladder In progress CDER 12/11/2017
Anticoagulants and Bleeding Events Complete CDER 05/20/2016
Cutaneous Small Vessel Vasculitis and Acute Kidney Injury Following Direct-Acting Oral Anticoagulant Use Complete CDER 09/16/2019
Infliximab Use Complete CDER 08/02/2012
Drug Use Among Pregnant Women with Live Births Complete CDER 01/30/2016
Phosphodiesterase Type 5 (PDE-5) Inhibitor Utilization Among Women Complete CDER 10/12/2018
Cardiovascular Therapy Agent Use 2 In progress CDER 09/23/2014
Length of Follow-up Time for New Users of Immunosuppressive Drugs Complete CDER 02/28/2018
Gastrointestinal Therapy Agents Use 2 In progress CDER 09/23/2014
Rhabdomyolysis and/or Creatine Kinase Laboratory Results Following New Use of Statins or Angiotensin-Converting Enzyme Inhibitors Complete CDER 03/01/2018
Chronic Kidney Disease Diagnoses Complete CDER 12/29/2013
Use of Cancer Drugs In progress CDER 12/08/2017
Dabigatran (Pradaxa), Warfarin and GI Bleed, Intracerebral Hemorrhage Complete CDER 02/11/2013
Multiple Sclerosis Relapses among Copaxone, Glatopa, Gilenya, and Glatiramer Users Complete CDER 09/17/2019
Injection Infliximab Procedures Complete CDER 08/02/2012
Anticoagulant Use Among Patients with Atrial Fibrillation Complete CDER 01/31/2016
Counts and Proportions of New Users of Fentanyl Transdermal System with Evidence of Prior Opioid Tolerance Complete CDER 11/06/2018
Occurrence of Selected Generic Drugs 12 In progress CDER 09/22/2014
Counts, Prevalence, and Incidence of Intravenous (IV) Iron Products In progress CDER 03/02/2018
Nursing Home HCPCS Codes Complete CDER 12/29/2013
Suicide Diagnoses Complete CDER 12/15/2017
Hydroxyprogesterone Caproate and Progesterone Use during Pregnancy Complete CDER 10/29/2019
Analgesics Use Complete CDER 08/02/2012
Parenteral Iron and Anaphylactoid Reactions Complete CDER 07/22/2016
Duration of Use for Teriparatide Complete CDER 11/29/2018
Antiepileptic Drugs (AEDs) and Kidney Stones 2 Complete CDER 09/23/2014
Combined Oral Contraceptives Containing Ethinyl Estradiol and Levonorgestrel and Venous Thromboembolism Complete CDER 03/04/2018
Prevalent and Incident Use of Quinine Sulfate Complete CDER 01/08/2014
Prevalent and Incident Use of Romiplostim In progress CDER 12/18/2017
Attention Deficit Hyperactivity Disorder (ADHD) Medications and Heart Failure Complete CDER 10/25/2016
Use of SGLT-2 Inhibitors and Obesity Drugs Complete CDER 11/08/2019
Dalfampridine Use Complete CDER 08/02/2012
Dabigatran and Warfarin Use Among Members with Atrial Fibrillation and Other Pre-Existing Conditions Complete CDER 07/21/2016
Pulmonary Arterial Hypertension and Interstitial Lung Disease Events Among Interleukin Inhibitor Users Complete CDER 12/03/2018
Infectious Disease Diagnoses Complete CDER 09/23/2014
Exposure to Intravenous (IV) Iron Procedures and Anaphylaxis and Epinephrine Events Complete CDER 03/02/2018
Quinine Sulfate, Diltiazem and Selected Thrombotic Events Complete CDER 01/08/2014
Gadolinium-Based Contrast Agents (GBCAs) Use in Pregnancy Complete CDER 04/04/2019